hydroxyproline has been researched along with pd 123319 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Frohlich, ED; Susic, D; Varagic, J | 1 |
| Fujimura, M; Ichikawa, Y; Inuzuka, K; Nakao, S; Nishizawa, Y; Tagami, A; Takato, H; Waseda, Y; Yasui, M | 1 |
2 other study(ies) available for hydroxyproline and pd 123319
| Article | Year |
|---|---|
Coronary hemodynamic and ventricular responses to angiotensin type 1 receptor inhibition in SHR: interaction with angiotensin type 2 receptors.
Topics: Angiotensin Receptor Antagonists; Animals; Aorta; Benzimidazoles; Biphenyl Compounds; Blood Pressure; Coronary Circulation; Heart Rate; Heart Ventricles; Hemodynamics; Hydroxyproline; Hypertension; Imidazoles; Male; Organ Size; Pyridines; Rats; Rats, Inbred SHR; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Tetrazoles; Vascular Resistance | 2001 |
Angiotensin II type 2 receptor antagonist reduces bleomycin-induced pulmonary fibrosis in mice.
Topics: Angiotensin II Type 1 Receptor Blockers; Angiotensin II Type 2 Receptor Blockers; Animals; Bleomycin; Blood Cell Count; Bronchoalveolar Lavage Fluid; Disease Models, Animal; Hydroxyproline; Imidazoles; Macrophage Inflammatory Proteins; Male; Mice; Mice, Inbred ICR; Pulmonary Fibrosis; Pyridines; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Tetrazoles; Tumor Necrosis Factor-alpha; Vasoconstrictor Agents | 2008 |